Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USADaniel A. Barocas, Rachel J. Spear, Denise Globe et al.|Advances in Urology|2012Cited by 36
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer CasesCheryl T. Lee, Thomas Bramley, Daniel A. Barocas et al.|The Journal of Urology|2012Cited by 34
Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarinAmanda M. Farr, John Graham, Yonghua Jing et al.|Hospital Practice|2015Cited by 14
Abstract 19672: Comparison of Major-bleeding Risk and Health Care Costs Among Treatment-naïve Non-valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or WarfarinAlpesh Amin, Jeffrey Trocio, Amanda Bruno et al.|Circulation|2015Cited by 4
Comparison of Short-Term Bleeding-Related Health Care Utilization and Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or WarfarinAlpesh Amin, Jeffrey Trocio, Allison Keshishian et al.|CHEST Journal|2015Cited by 3